FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

• by Kathryn Wighton

• June 15, 2026

AI cuts lesion measurement time by 34%

Automated lesion measurements increased agreement on treatment response, although expert-generated proposals were accepted more often and required fewer adjustments.

• by Andrea Surnit

• September 3, 2026

• 4 min

Tenderness Tracks Ultrasound Findings

Joint tenderness showed broader associations with concurrent ultrasound abnormalities than patient-reported pain among anti-cyclic citrullinated peptide–positive patients without clinical arthritis.

• by Andrea Surnit

• July 20, 2026

• 5 min

FDA Approves New Iohexol Vials

The approval includes additional 300 mg iodine/mL and 350 mg iodine/mL vial presentations.

• by Kathryn Wighton

• July 17, 2026

• 2 min